Montgomery County Executive Marc Elrich joined Maryland Secretary of State Susan Lee, Department of Commerce Secretary Harry Coker Jr., County Council President Natali Fani-González and other local officials to celebrate the launch of Bora Biologics’ drug substance manufacturing facility in Rockville. Bora Group acquired MacroGenics’ GMP manufacturing operations and biologics manufacturing facility for $122.5 million and will continue to make products for MacroGenics while also offering expanded contract manufacturing capacity for other pharma companies.
The Taiwan-based company announced it is retaining the 140 employees who previously worked at the site for MacroGenics and plans to add more jobs and capital investment in the near future. The Bora Biologics facility includes FDA-approved manufacturing capabilities supporting both clinical and commercial-stage biologics production.
“Companies like Bora Pharmaceuticals are what makes Maryland a global leader in the life sciences. They bring talent, innovation, and a commitment to delivering transformative treatment to patients,” said Maryland Commerce Secretary Harry Coker Jr. “We are thrilled that Bora has once again chosen Maryland as they continue to grow and serve patients around the world.”
The County is home to more than 350 life sciences companies and serves as the anchor of the BioHealth Capital Region, the nation’s third-largest biopharmaceutical cluster in the U.S.
Advertisement
“We welcome Bora Biologics to Montgomery County, are happy they’ve retained all the employees who used to work for MacroGenics, and are excited about their plans to invest and grow more jobs here,” said County Executive Elrich. “Our highly educated and diverse community, and our ongoing investments in workforce development and innovation lead to more jobs here and also ensure the next generation of life-saving therapies can be developed and produced right here in the County.”
Bora’s acquisition of MacroGenics’ GMP manufacturing operations and biologics manufacturing facility follows a wave of other international companies making investments in the County. In the past several years, the County has welcomed a growing number of foreign-headquartered life sciences and advanced technology companies seeking to establish or expand U.S. operations, attracted by the County’s highly skilled workforce, proximity to federal research agencies, and innovation economy.
“We are excited to have Bora Biologics join the dynamic biotechnology and life sciences sector in Montgomery County,” said Council President and Chair of the Economic Development Committee Fani-González. “It’s important that we celebrate this moment and continue to share all the incredible economic development assets Montgomery County has to offer for businesses across the globe.”
This expansion also adds momentum to a growing number of contract development and manufacturing organizations (CDMOs) operating in Montgomery County. CDMOs are companies that help drug and biotech firms develop, make, and sometimes package their medicines instead of doing it themselves. As demand for biologics manufacturing and pharmaceutical supply chain capacity continues to grow, the County has emerged as a leading location for contract development and manufacturing organizations supporting the development and commercialization of next-generation therapies.
“This acquisition establishes a U.S. biologics manufacturing platform that sponsors can depend on, from development through licensed commercial supply,” said Chairman and CEO of Bora Group Bobby Sheng. “As regulatory and supply chain dynamics continue to evolve, we expect biotech and pharmaceutical companies to increasingly seek manufacturing partners with U.S.-based, inspection-proven infrastructure. Bora Biologics is designed to meet that need, offering a fully integrated, end-to-end biologics platform spanning drug substance and drug product capabilities.”
Advertisement
In May, Bora Pharmaceuticals was recognized as one of Time magazine’s “World’s Most Impactful Companies 2026.” The ranking evaluates 500 organizations that are driving measurable positive impacts on society, the environment, and the economy, utilizing science-based net-impact data. The list spans industries from technology and energy to finance and health care, with honorees in the health care sector including Moderna, Pfizer, and Novo Nordisk.
“Today’s launch is another signal that Montgomery County’s innovation economy is thriving and continues to attract world-class companies from around the globe,” said Jared Smith, president and CEO of the Montgomery County Economic Development Corporation. “Bora Biologics’ decision to invest in Rockville demonstrates the strength of our ecosystem and the growing demand for advanced biomanufacturing capabilities. Congratulations to Bora Pharmaceuticals and Montgomery County on this significant milestone.”
# # #
Read the original article at mcgov